News Sentiment

HRTX sentiment intelligence

Heron Therapeuti news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 44 Balanced news tone 50 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.41 Week of 10 Jul 2026
Weighted tone 44/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

76/100 classification confidence.

Company focus 41

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-5.5% over one week, +3.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Consensus Rating of "Hold" from Brokerages

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 76/100 classification
One-week reaction -5.5% Price reacting lower
Trend fit Trend inactive 3.6% over four weeks
Fair value -76.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 27
Negative 17

Relevance

Why the article matched

Direct first
Direct company coverage 41
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 12
TradingView 6
Stock Titan 5
TradingKey 5
Investing.com 4
AD HOC NEWS 3
Moomoo 3
simplywall.st 3

Event Lens

What the news is about

Classified themes
Market update 22
Earnings 18
Analyst action 6
Regulatory and legal 2
Capital return 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-50 of 50